The growth of the cell culture media market is driven by rising demand for biopharmaceuticals, vaccines, and cell-based therapies, fueled by advancements in biotechnology and life sciences research.

The 80-year-old partnership between the federal government and research institutions has made the U.S. the leader in scientific innovation. But now a proposed funding cut threatens the arrangement.